アルボウイルス検査市場：タイプ、成分、適応症、エンドユーザー別-2025-2030年の世界予測

アルボウイルス検査市場は、2023年に12億4,000万米ドルと評価され、2024年には13億1,000万米ドルに達すると予測され、CAGR 5.81％で成長し、2030年には18億5,000万米ドルになると予測されています。

アルボウイルス検査は、蚊やダニなどの節足動物を介してヒトや動物に感染するウイルスであるアルボウイルスの存在を検出するために採用される診断手順を指します。ジカ熱、デング熱、西ナイルウイルスなどのアルボウイルス感染症が増加していることから、主に公衆衛生を守るためにアルボウイルス検査の必要性が高まっています。この検査は、臨床とベクターサーベイランスの両面で極めて重要であり、病院、診断ラボ、研究機関、現場サーベイランスユニットなどに応用されています。市場の成長には、媒介感染症に対する意識の高まり、アウトブレイクコントロールのための政府の取り組みの増加、PCRや血清学的手法を含む診断技術の進歩が寄与しています。迅速で正確なポイントオブケア検査ソリューションに対する需要が急増していることから、特に流行地域では新たなビジネスチャンスが生まれています。しかし、先進的な検査機器の高価格、農村部や資源の乏しい環境における物流の課題、高度な診断ツールを操作する熟練者の不足など、いくつかの要因が市場拡大を妨げています。技術革新の主な分野としては、低コストの携帯型診断キットの開発、検査法の特異性と感度の向上、人工知能を統合したアウトブレイク予測などが挙げられます。さらに、血清学的検査におけるアルボウイルスの変異パターンや交差反応性を理解するための調査を重視することで、進歩を促進することができます。企業は、普及を促進するために政府やNGOとの協力を検討し、早期診断の重要性を強調する教育キャンペーンを展開すべきです。アルボウイルス検査市場は成長しつつあるが、本質的にダイナミックであり、季節動向、地域的な疾病流行、保健政策の変更に影響されます。そのため、この分野の企業は機敏性を維持し、研究開発投資に優先順位をつけ、データ分析を活用して新たな動向を把握し、多様な地域のニーズに合わせて製品を調整することで、進化する公衆衛生の状況の中で市場での確固たる地位を確保する必要があります。

市場力学：急速に進化するアルボウイルス検査市場の主要市場インサイトを公開

アルボウイルス検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 人口におけるアルボウイルスの有病率の上昇
  • 各国におけるヘルスケアに対する意識の高まりと支出の増加
• 市場抑制要因
  • アルボウイルス検査法に伴う精度の問題
• 市場機会
  • 蚊が媒介するデング熱を撲滅するための新しい検査モデルの進化
  • 近代化されたヘルスケア・インフラへの急速な投資
• 市場の課題
  • アルボウイルス検査の厳しい承認プロセス

ポーターのファイブフォース：アルボウイルス検査市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、アルボウイルス検査市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：アルボウイルス検査市場における外部からの影響の把握

外部マクロ環境要因は、アルボウイルス検査市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析アルボウイルス検査市場における競合情勢の把握

アルボウイルス検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスアルボウイルス検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、アルボウイルス検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨アルボウイルス検査市場における成功への道筋を描く

アルボウイルス検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報に基づいた意思決定を行う上で役立つ重要な質問にも回答しています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 人口におけるアルボウイルスの蔓延率の上昇
    • 各国でヘルスケア意識と支出が増加
  • 抑制要因
    • アルボウイルス検査メソッドに関連する精度の問題
  • 機会
    • 蚊媒介デング熱を撲滅するための新しい検査モデルの進化
    • 近代化されたヘルスケアインフラへの急速な投資
  • 課題
    • アルボウイルス検査の厳格な承認プロセス
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 アルボウイルス検査市場：タイプ別

• 酵素免疫測定法（ELISA）
• RT-PCRアッセイ

第7章 アルボウイルス検査市場：コンポーネント別

• 機器と設備
• 研究室消耗品
• ソフトウェアとデータ管理ソリューション

第8章 アルボウイルス検査市場適応症別

• チクングニア熱
• デング熱
• ウエストナイル熱
• 黄熱ウイルス
• ジカ熱

第9章 アルボウイルス検査市場：エンドユーザー別

• 診断センター
• 病院
• 調査機関

第10章 南北アメリカのアルボウイルス検査市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のアルボウイルス検査市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのアルボウイルス検査市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Abnova Corporation
• Bio-Rad Laboratories, Inc.
• Biogenix Inc. Pvt. Ltd.
• Biolab Diagnostics{I}Pvt. Ltd.
• bioMerieux SA
• Certest Biotec, S.L.
• Creative Diagnostics
• Diasorin S.p.A.
• EUROIMMUN Medizinische Labordiagnostika AG
• F. Hoffmann-La Roche Ltd.
• Getein Biotech, Inc.
• Hologic, Inc.
• InBios International, Inc.
• Intec Products, Inc.
• Lexicare Pharma Pvt. Ltd.
• NovaTec Immundiagnostica GmbH
• OriGene Technologies, Inc.
• PerkinElmer, Inc.
• Quest Diagnostics
• Reckon Diagnostics Pvt. Ltd.
• Response Biomedical Corporation
• SD Biosensor Inc.
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. ARBOVIRUS TESTING MARKET RESEARCH PROCESS
• FIGURE 2. ARBOVIRUS TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ARBOVIRUS TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. ARBOVIRUS TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. ARBOVIRUS TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ARBOVIRUS TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ARBOVIRUS TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ARBOVIRUS TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAYS (ELISAS), BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY RT-PCR ASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY INSTRUMENTS & EQUIPMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY LABORATORY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY SOFTWARE & DATA MANAGEMENT SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY CHIKUNGUNYA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY DENGUE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY WEST NILE FEVER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY YELLOW FEVER VIRUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY ZIKA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. CANADA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. CANADA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 39. CANADA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 40. CANADA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. CHINA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. CHINA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 61. CHINA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 62. CHINA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. INDIA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. INDIA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 65. INDIA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 66. INDIA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. ITALY ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 133. ITALY ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 134. ITALY ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 135. ITALY ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. POLAND ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 149. POLAND ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 150. POLAND ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 151. POLAND ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 152. QATAR ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 153. QATAR ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 154. QATAR ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 155. QATAR ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 192. ARBOVIRUS TESTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 193. ARBOVIRUS TESTING MARKET, FPNV POSITIONING MATRIX, 2023

The Arbovirus Testing Market was valued at USD 1.24 billion in 2023, expected to reach USD 1.31 billion in 2024, and is projected to grow at a CAGR of 5.81%, to USD 1.85 billion by 2030.

Arbovirus testing refers to the diagnostic procedures employed to detect the presence of arboviruses, which are viruses transmitted to humans and animals via arthropods like mosquitoes and ticks. Given the rising incidence of arboviral infections such as Zika, Dengue, and West Nile Virus, the necessity for arbovirus testing has intensified, primarily to safeguard public health. This testing is crucial in both clinical and vector surveillance contexts and has applications spanning hospitals, diagnostic labs, research institutes, and field surveillance units. Market growth is fueled by heightened awareness of vector-borne diseases, increased government initiatives for outbreak control, and advancements in diagnostic technologies, including PCR and serological methods. The burgeoning demand for rapid, accurate, and point-of-care testing solutions spotlights an emerging opportunity, especially in endemic regions. However, market expansion is hindered by several factors: the high cost of advanced testing devices, logistical challenges in rural or resource-poor settings, and a shortage of skilled personnel to operate sophisticated diagnostic tools. Key areas for innovation include the development of low-cost portable diagnostic kits, enhancing the specificity and sensitivity of testing methods, and integrating artificial intelligence to predict outbreaks. Furthermore, emphasis on research to understand arbovirus mutation patterns and cross-reactivity in serological tests can propel advancements. Firms should consider collaborations with governments and NGOs to facilitate widespread adoption and deploy educational campaigns to amplify the significance of early diagnosis. The arbovirus testing market, while growing, is inherently dynamic and influenced by seasonal trends, regional disease prevalence, and health policy changes. As such, businesses in this domain must maintain agility, prioritize R&D investment, and leverage data analytics to capture emerging trends and tailor products to meet diverse regional needs, thereby securing a robust market position amidst evolving public health landscapes.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Arbovirus Testing Market

The Arbovirus Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising rate of prevalence of arboviruses among population
  • Growing healthcare awareness and spending across economies
• Market Restraints
  • Accuracy issues associated with arbovirus testing methods
• Market Opportunities
  • Evolution of new testing model to swat mosquito-borne dengue fever
  • Rapid investments in modernized healthcare infrastructures
• Market Challenges
  • Stringent approval processes for arbovirus testing

Porter's Five Forces: A Strategic Tool for Navigating the Arbovirus Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Arbovirus Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Arbovirus Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Arbovirus Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Arbovirus Testing Market

A detailed market share analysis in the Arbovirus Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Arbovirus Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Arbovirus Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Arbovirus Testing Market

A strategic analysis of the Arbovirus Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Arbovirus Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abnova Corporation, Bio-Rad Laboratories, Inc., Biogenix Inc. Pvt. Ltd., Biolab Diagnostics {I}Pvt. Ltd., bioMerieux SA, Certest Biotec, S.L., Creative Diagnostics, Diasorin S.p.A., EUROIMMUN Medizinische Labordiagnostika AG, F. Hoffmann-La Roche Ltd., Getein Biotech, Inc., Hologic, Inc., InBios International, Inc., Intec Products, Inc., Lexicare Pharma Pvt. Ltd., NovaTec Immundiagnostica GmbH, OriGene Technologies, Inc., PerkinElmer, Inc., Quest Diagnostics, Reckon Diagnostics Pvt. Ltd., Response Biomedical Corporation, SD Biosensor Inc., Siemens Healthineers AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Arbovirus Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Enzyme-linked Immunosorbent Assays (ELISAs) and RT-PCR Assays.
• Based on Component, market is studied across Instruments & Equipments, Laboratory Consumables, and Software & Data Management Solutions.
• Based on Indication, market is studied across Chikungunya, Dengue, West Nile Fever, Yellow Fever Virus, and Zika.
• Based on End-User, market is studied across Diagnostic Centers, Hospitals, and Research Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising rate of prevalence of arboviruses among population
    • 5.1.1.2. Growing healthcare awareness and spending across economies
  • 5.1.2. Restraints
    • 5.1.2.1. Accuracy issues associated with arbovirus testing methods
  • 5.1.3. Opportunities
    • 5.1.3.1. Evolution of new testing model to swat mosquito-borne dengue fever
    • 5.1.3.2. Rapid investments in modernized healthcare infrastructures
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent approval processes for arbovirus testing
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Arbovirus Testing Market, by Type

• 6.1. Introduction
• 6.2. Enzyme-linked Immunosorbent Assays (ELISAs)
• 6.3. RT-PCR Assays

7. Arbovirus Testing Market, by Component

• 7.1. Introduction
• 7.2. Instruments & Equipments
• 7.3. Laboratory Consumables
• 7.4. Software & Data Management Solutions

8. Arbovirus Testing Market, by Indication

• 8.1. Introduction
• 8.2. Chikungunya
• 8.3. Dengue
• 8.4. West Nile Fever
• 8.5. Yellow Fever Virus
• 8.6. Zika

9. Arbovirus Testing Market, by End-User

• 9.1. Introduction
• 9.2. Diagnostic Centers
• 9.3. Hospitals
• 9.4. Research Institutes

10. Americas Arbovirus Testing Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Arbovirus Testing Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Arbovirus Testing Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Abnova Corporation
• 3. Bio-Rad Laboratories, Inc.
• 4. Biogenix Inc. Pvt. Ltd.
• 5. Biolab Diagnostics {I}Pvt. Ltd.
• 6. bioMerieux SA
• 7. Certest Biotec, S.L.
• 8. Creative Diagnostics
• 9. Diasorin S.p.A.
• 10. EUROIMMUN Medizinische Labordiagnostika AG
• 11. F. Hoffmann-La Roche Ltd.
• 12. Getein Biotech, Inc.
• 13. Hologic, Inc.
• 14. InBios International, Inc.
• 15. Intec Products, Inc.
• 16. Lexicare Pharma Pvt. Ltd.
• 17. NovaTec Immundiagnostica GmbH
• 18. OriGene Technologies, Inc.
• 19. PerkinElmer, Inc.
• 20. Quest Diagnostics
• 21. Reckon Diagnostics Pvt. Ltd.
• 22. Response Biomedical Corporation
• 23. SD Biosensor Inc.
• 24. Siemens Healthineers AG
• 25. Thermo Fisher Scientific Inc.